S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Overlooked AI Stock Gets Urgent "Buy" (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Analysts Went All In On These Computer Stocks, Save Your Spot
The single greatest medical breakthrough of all time? (Ad)
Things to know about California's new proposed rules for insurance companies
KB Home Price Weakness is a Signal to Buy this Cash Machine
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
3 Reasons This Sleeping Giant Is About To Wake Up
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Overlooked AI Stock Gets Urgent "Buy" (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Analysts Went All In On These Computer Stocks, Save Your Spot
The single greatest medical breakthrough of all time? (Ad)
Things to know about California's new proposed rules for insurance companies
KB Home Price Weakness is a Signal to Buy this Cash Machine
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
3 Reasons This Sleeping Giant Is About To Wake Up
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Overlooked AI Stock Gets Urgent "Buy" (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Analysts Went All In On These Computer Stocks, Save Your Spot
The single greatest medical breakthrough of all time? (Ad)
Things to know about California's new proposed rules for insurance companies
KB Home Price Weakness is a Signal to Buy this Cash Machine
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
3 Reasons This Sleeping Giant Is About To Wake Up
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Overlooked AI Stock Gets Urgent "Buy" (Ad)
52-week Low Names To Tip The Upside Scale In Your Favor
Analysts Went All In On These Computer Stocks, Save Your Spot
The single greatest medical breakthrough of all time? (Ad)
Things to know about California's new proposed rules for insurance companies
KB Home Price Weakness is a Signal to Buy this Cash Machine
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
3 Reasons This Sleeping Giant Is About To Wake Up
NYSEAMERICAN:OGEN

Oragenics (OGEN) Stock Forecast, Price & News

$2.77
-0.25 (-8.28%)
(As of 09/22/2023 ET)
Compare
Today's Range
$2.77
$3.01
50-Day Range
$2.94
$4.18
52-Week Range
$2.60
$17.40
Volume
2,463 shs
Average Volume
7,098 shs
Market Capitalization
$7.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

OGEN stock logo

About Oragenics (NYSEAMERICAN:OGEN) Stock

Oragenics, Inc., a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

OGEN Price History

OGEN Stock News Headlines

Oragenics (NYSEAMERICAN:OGEN) Now Covered by StockNews.com
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Oragenics, Inc. Announces Private Placement
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Oragenics, Inc. Regains Compliance with NYSE American
Oragenics, Inc. Receives NYSE American Notice
Oragenics, Inc. Announces New Chair
Oragenics Inc OGEN Stock Quote
See More Headlines
Receive OGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter.

OGEN Company Calendar

Last Earnings
8/14/2023
Today
9/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:OGEN
Employees
6
Year Founded
N/A

Profitability

Net Income
$-14,290,000.00
Pretax Margin
-10,347.41%

Debt

Sales & Book Value

Annual Sales
$130,000.00
Book Value
$5.64 per share

Miscellaneous

Free Float
2,333,000
Market Cap
$7.04 million
Optionable
Not Optionable
Beta
0.52
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Ms. Kimberly M. Murphy (Age 60)
    Pres, CEO & Director
    Comp: $550.93k
  • Dr. Martin Handfield M.Sc. (Age 52)
    Ph.D., Chief Scientific Officer
    Comp: $264.77k
  • Ms. Janet Huffman (Age 51)
    CFO, Sec. & Treasurer













OGEN Stock - Frequently Asked Questions

How have OGEN shares performed in 2023?

Oragenics' stock was trading at $0.1051 at the start of the year. Since then, OGEN shares have increased by 2,535.6% and is now trading at $2.77.
View the best growth stocks for 2023 here
.

Are investors shorting Oragenics?

Oragenics saw a decrease in short interest during the month of August. As of August 15th, there was short interest totaling 23,400 shares, a decrease of 23.8% from the July 31st total of 30,700 shares. Based on an average daily trading volume, of 10,000 shares, the short-interest ratio is currently 2.3 days. Approximately 1.0% of the shares of the company are sold short.
View Oragenics' Short Interest
.

How were Oragenics' earnings last quarter?

Oragenics, Inc. (NYSEAMERICAN:OGEN) issued its quarterly earnings results on Monday, August, 14th. The biotechnology company reported ($1.51) earnings per share (EPS) for the quarter. The biotechnology company earned $0.01 million during the quarter.

When did Oragenics' stock split?

Oragenics's stock reverse split before market open on Monday, January 23rd 2023. The 1-60 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Oragenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oragenics investors own include Imunon (CLSN), Jaguar Health (JAGX), Biocept (BIOC), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Amarin (AMRN), Heat Biologics (HTBX), Idera Pharmaceuticals (IDRA) and Achieve Life Sciences (ACHV).

What is Oragenics' stock symbol?

Oragenics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "OGEN."

Who are Oragenics' major shareholders?

Oragenics' stock is owned by a number of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.65%). Insiders that own company stock include Fred Telling, Joseph Hernandez, Michael O'keefe Sullivan and Robert C Koski.
View institutional ownership trends
.

How do I buy shares of Oragenics?

Shares of OGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Oragenics' stock price today?

One share of OGEN stock can currently be purchased for approximately $2.77.

How much money does Oragenics make?

Oragenics (NYSEAMERICAN:OGEN) has a market capitalization of $7.04 million and generates $130,000.00 in revenue each year.

How can I contact Oragenics?

Oragenics' mailing address is 4902 Eisenhower Blvd Ste 125, TAMPA, FL 33634-6342, United States. The official website for the company is www.oragenics.com. The biotechnology company can be reached via phone at 813-286-7900, via email at johnm@coreir.com, or via fax at 813-286-7904.

This page (NYSEAMERICAN:OGEN) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -